Results 291 to 300 of about 6,889,134 (415)

Recent advances and future directions in urinary system tissue engineering. [PDF]

open access: yesMater Today Bio
Yuan J   +5 more
europepmc   +1 more source

Multidimensional OMICs reveal ARID1A orchestrated control of DNA damage, splicing, and cell cycle in normal‐like and malignant urothelial cells

open access: yesMolecular Oncology, EarlyView.
Loss of the frequently mutated chromatin remodeler ARID1A, a subunit of the SWI/SNF cBAF complex, results in less open chromatin, alternative splicing, and the failure to stop cells from progressing through the cell cycle after DNA damage in bladder (cancer) cells. Created in BioRender. Epigenetic regulators, such as the SWI/SNF complex, with important
Rebecca M. Schlösser   +11 more
wiley   +1 more source

Sound innovations for biofabrication and tissue engineering. [PDF]

open access: yesMicrosyst Nanoeng
Wu M   +11 more
europepmc   +1 more source

Development of regenerated cardiomyocyte for the cardiovascular tissue engineering

open access: bronze, 2001
Keiichi Fukuda   +5 more
openalex   +2 more sources

Escape from TGF‐β‐induced senescence promotes aggressive hallmarks in epithelial hepatocellular carcinoma cells

open access: yesMolecular Oncology, EarlyView.
Chronic TGF‐β exposure drives epithelial HCC cells from a senescent state to a TGF‐β resistant mesenchymal phenotype. This transition is characterized by the loss of Smad3‐mediated signaling, escape from senescence, enhanced invasiveness and metastatic potential, and upregulation of key resistance modulators such as MARK1 and GRM8, ultimately promoting
Minenur Kalyoncu   +11 more
wiley   +1 more source

Adaptability of Electrospun PVDF Nanofibers in Bone Tissue Engineering. [PDF]

open access: yesPolymers (Basel)
Havlíková T   +6 more
europepmc   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

open access: yesMolecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau   +11 more
wiley   +1 more source

Tissue Engineering Is Under Way

open access: yesEngineering, 2017
Xiaosong Gu
doaj   +1 more source

Home - About - Disclaimer - Privacy